Diagnostyka S.A. (GPW: DIA) Stock Analysis & Fundamentals | ScreenerHero

Create free account

DIADiagnostyka S.A.

GPW · PL · Healthcare · Diagnostics & Research · diag.pl

181.50PLN+1.11%Mkt Cap: 1.55B $P/E: 23.451d ago

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Cheaper

P/B

Pricier

Div Yield

Lower

1M Perf

Avg

Thermo Fisher Scientific Inc.

$194.52BUSDP/E 28.7

Danaher Corporation

$140.09BUSDP/E 38.3

$45.77BUSDP/E 44.2

IDEXX Laboratories, Inc.

$44.00BUSDP/E 41.0

Waters Corporation

$37.24BUSDP/E 48.3

Agilent Technologies, Inc.

$36.91BUSDP/E 26.2

IQVIA Holdings Inc.

$34.55BUSDP/E 25.7

$28.55BUSDP/E 34.4

Mettler-Toledo International Inc.

$26.44BUSDP/E 30.8

Quest Diagnostics Incorporated

$23.88BUSDP/E 23.8

Labcorp Holdings Inc.

$23.53BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.92BUSDP/E 35.1

Eurofins Scientific SE

$13.05BUSDP/E 27.2

$12.69BUSDP/E 54.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.90BUSDP/E 20.8

Twist Bioscience Corporation

BillionToOne, Inc.

$5.54BUSDP/E 222.9

Sotera Health Company

$5.11BUSDP/E 43.7

$4.55BUSDP/E 52.9

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.53BUSDP/E 38.8

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.03BUSDP/E 21.7

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$305.89MUSDP/E 3.1

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.1

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.08MUSDP/E 63.3

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Avricore Health Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.55B $

Enterprise Value1.76B $

Revenue (TTM)635.92M $

Gross Profit482.57M $

Net Income (TTM)63.72M $

Revenue/Share18.84 USD

Last Price181.50 PLN

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees8.6K

CountryPL

SectorHealthcare

IndustryDiagnostics & Research

ISINPLDGNST00012

Valuation

P/E (Trailing)23.45

P/E (Forward)16.40

PEG—

EV/EBITDA11.50

EV/Revenue2.77

P/S2.34

P/B9.70

EPS (TTM)7.75

EPS (Forward)—

52W Range

146.4048% of range219.90

52W High219.90 PLN

52W Low146.40 PLN

Profitability

Gross Margin79.05%

Oper. Margin18.06%

EBITDA Margin24.09%

Profit Margin10.44%

ROE47.62%

ROA12.16%

Growth

Revenue Growth14.60%

Earnings Growth13.30%

Cash Flow & Leverage

Operating CF139.74M $

CapEx (TTM)51.86M $

FCF Margin10.61%

FCF Yield4.35%

Net Debt270.83M $

Net Debt/EBITDA1.77

Balance Sheet

Debt/Equity2.05

Current Ratio0.80

Quick Ratio0.68

Book Value/Sh17.91 PLN

Cash/Share1.081 PLN

Dividends

Fwd Div Rate4.400 PLN

Trail. Div Rate4.400 PLN

Div. Yield2.51%

5Y Avg Yield—

Payout Ratio42.76%

Ex-Div DateJun 1, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)206.28 PLN

Upside (mean)+13.7%

Target Range188.00 PLN – 217.00 PLN

PLN188.00+13.7% to meanPLN217.00

# Analysts6

Ownership

Shares Out.33.76M

Float16.40M

Insiders47.20%

Institutions16.11%

Technical

SMA 50165.21 (+9.9%)

SMA 200178.11 (+1.9%)

Beta—

S&P 52W Chg20.05%

Avg Vol (30d)42.55K

Avg Vol (10d)35.67K

Technical Indicators

RSI (14)68.6

MACD2.5223

MACD Signal2.2126

MACD Hist.+0.3097

BB Upper179.80 PLN

BB Middle174.51 PLN

BB Lower169.23 PLN

BB Width6.06%

ATR (14)4.089 PLN

Vol Ratio (20d)1.20x